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r
The amount of oxidative phosphorylation enzymes in mitochondrial encephalomyopathy patients has 
been studied by two-dimensional electrophoresis (blue native PAGE/Tricine-SDS-PAGE). Only 20 mg 
muscle was required to identify and analyse complexes I, III, IV, and V after Coomassie staining. In most 
cases reduced amounts of the involved complex(es) correlated well with decreased enzyme activities. The 
reliability of the method was reflected by the constant mutual ratio of the complexes found in all controls. 
Deviations from normal ratios were found to be more sensitive indicators for a defect than the absolute 
quantities, which varied considerably within the control group both in the enzymic and in the electropho­
retic analysis. The effect of the mitochondrial tRNALcu(UUR) mutation in mitochondrial myopathy, encepha­
lopathy, lactic acidosis, and stroke-like episodes on the amount of oxidative phosphorylation complexes 
was demonstrated for the first time directly on the protein level. In patients without known DNA 
mutations, specific defects of single complexes were identified. The new technique is a sensitive method 
for the identification of oxidative phosphorylation defects, complementary to enzymic measurements.
Keywords. Mitochondrial encephalomyopathies; respiratory chain deficiencies; blue native electrophore­
sis; mtDNA.
Mitochondrial myopathies are a heterogeneous group of dis­
orders affecting predominantly skeletal muscle and the central 
nervous system. A defect in the mitochondrial energy metabo­
lism is thought to be the primary cause of disease [1, 2]. Each 
mitochondrion contains its own mtDNA that codes for 13 genes 
of oxidative phosphorylation (OXPHOS) proteins plus the two 
structural rRNAs and 22 tRNAs necessary for expression [3]. 
Recently, several mutations of mtDNA have been described in 
association with mitochondrial encephalomyopathies or other 
neurological disorders [4]. Examples of these are large-scale 
deletions of mtDNA in chronic progressive external ophthal­
moplegia (CPEO) [5], point mutations in the mitochondrial 
tRNALcu(ULm> or the tRNALys gene in mitochondrial myopathy, 
encephalopathy, lactic acidosis and stroke-like episodes 
(MELAS) [6] and in myoclonic epilepsy and ragged-red fibers 
(MERRF) [7], or in the gene coding for the ATPase 6 subunit 
in Leigh’s syndrome [8]. These mutations are usually found only 
in a proportion of the mtDNA molecules (heteroplasmy), which 
may vary between different tissues and which determines the 
phenotypic expression of the mutation in a given tissue.
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Abbreviations. CPEO, chronic progressive external ophthalmo­
plegia; MELAS, mitochondrial myopathy, encephalopathy, lactic acido­
sis, and strokelike episodes; OXPHOS, oxidative phosphorylation ; 2D, 
two-dimensional; m„pp, apparent molecular mass.
Biochemical analysis of muscle tissue varied from severe 
isolated or combined deficiencies of complex I and complex IV 
to no apparent defects [9 — 11]. In a large proportion of patients 
with respiratory-chain enzyme deficiencies, no mtDNA muta­
tions have been found [12, 13]. These defects could have arisen 
from mutations in the nDNA, although such mutations have not 
yet been identified.
In the present study we used a quantitative two-dimensional 
electrophoretic procedure (blue native electrophoresis/Tricine- 
SDS-PAGE) to analyse the amount of assembled OXPHOS 
complexes in mitochondrial encephalomyopathy patients with 
mtDNA mutations and/or enzyme defects in the respiratory 
chain.
MATERIALS AND METHODS
Chemicals. Dodecyl /J-D-maltoside was from Boehringer 
Mannheim, 6-aminohexanoic acid from Fluka, acrylamide and 
bisacrylamide (the commercial twice-crystallized products), and 
Serva blue G (Coomassie blue G 250) from Serva. All other 
chemicals were from Sigma.
Electrophoretic techniques and sample preparation* The 
sample preparation for blue native PAGE started from 20 mg 
muscle that was homogenized with 250 \i\ 440 mM sucrose,
1 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 20 mM 
Na/Mops pH 7.2, by using a tightly fitting glass/Teflon homoge- 
nizer. After a 20-min centrifugation at 20000 g, the supernatant
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was discarded and the sediment was suspended in 40 p.1 1 M 
aminohexanoic acid, 50 mM Bistris/HCl pH 7.0, by twirling 
with a tiny spatula. The membrane proteins were solubilized by 
adding 15 pi 10% (mass/vol.) dodecylmaltoside. After a 15-min 
centrifugation at 100000 g% the supernatant was collected, 7,5 fil 
5% (mass/vol.) Serva blue G in 1 M aminohexanoic acid 
was added, and the total volume was applied to gel wells 
(lOm m X 1.6 mm) in blue native PAGE, that was performed as 
described [14]. Second dimension Tricine-SDS-PAGE starting 
from individual lanes from blue native PAGE was performed as 
described previously [15],
Staining and quantification. All two-dimensional (2D) gels 
were stained with Coomassie blue G 250 [16]. Densitometric 
quantification was performed with a personal densitometer 
(a laser scanning densitometer from Molecular Dynamics, 
Krefeld), and a Quick Scan Jr filter-densitometer (Desaga, Hei­
delberg) using a 595-nm filter. The personal densitometer al­
lowed one to use rectangles around individual bands and to 
quantify the absolute staining intensity of bands. The filter-den­
sitometer was used for one-dimensional scanning through the 
lanes of the characteristic polypeptide patterns. A 5-mm-broad 
slit was used in order to include the most intensely stained part 
of the bands. Both quantification techniques essentially gave the 
same results.
Several successive steps were applied for quantification of 
2D gels. First, the staining intensity of selected protein subunits 
of complexes w as measured. The selected bands, marked by ar­
rows in Fig. 1 A, were: the 75-kDa, the unresolved 51-kDa and 
49-kDa, and the 39-kDa subunit of complex I [17], subunits a, /i,
7, b, d, and a of complex V [18], core proteins I and II together, 
cytochrome b, iron-sulfur protein, 13.4-kDa and 9*5-kDa pro­
teins of complex III [19], subunits II (apparent molecular mass, 
/napi), about 20 kDa), IV (roaDD 16 kDa), Va,b (one band, mapp
11 kDa), Via,b,c (two bands, marp around 9 kDa) of complex IV 
[20]. Then the average staining intensity of each individual band 
from the control group was set to 1.00 and the staining intensity 
of individual bands from patient samples was compared to the 
corresponding average staining intensity from the controls. The 
mean value of these percentages was taken as the percentage 
of holo-complex in the patient sample. One of the quantified 
complexes (complex V in the present work, complex III in the 
studies of Alzheimer disease in the following paper in this vol­
ume) was then used as an internal reference in order to obtain 
the mutual ratios of complexes in each individual gel.
Patients. Seven patients were selected for this study based 
upon low respiratory-chain enzyme activities and/or mtDNA 
mutations observed in skeletal muscle biopsies* A brief over­
view of some clinical and laboratory data is presented in 
Table 1.
The two patients with the MEL AS syndrome (P3 and P4) 
carried the heteroplasmic A3243G mutation in 50% and 60% of 
their mtDNA, respectively, in their skeletal muscle. Riboflavin 
therapy in patient P3 has been previously described [21]. The 
two CPEO patients (P6 and P7) earned a large heteroplasmic 
deletion in 50% and 75%, respectively, of their muscle mtDNA. 
This deletion included the cytochrome-c oxidase III gene (COX 
III). All other patients and controls were free of known mtDNA 
mutations associated with mitochondrial myopathies or respira- 
tory-chain defects [4],
Control specimens for enzymic measurements were consid­
ered those in which a mitochondrial defect had been excluded 
by normal substrate oxidation rates of intact mitochondria and 
individual enzyme activities, as described previously [22]. The 
control group for 2D electrophoretic analysis consisted of ten 
patients with normal individual OXPHOS enzyme activities.
Morphology and biochemistry. All specimens of quadri­
ceps muscle were removed by surgical biopsy, whereafter the 
fresh tissue was processed for histochemical and biochemical 
studies. From patients PI and P2 autopsy specimens, that had 
been removed within 1 h of death, were also studied. The 
oxidation rates of radiolabeled substrates (pyruvate, malate, and 
succinate), and the activities of enzyme complexes of the respi­
ratory chain were measured in 600# supernatants of muscle 
homogenates [22, 23]. Cytochrome c oxidase (complex IV) 
was determined according to Cooperstein and Lazarow [24] 
and citrate synthase according to Srere [25]. The rotenone-sensi- 
tive NADH:ubiquinone-l oxidoreductase (complex I), and 
NADH:02 oxidoreductase (complex I-III-IV) were measured 
according to Fischer et a l [22]. Ubiquinone-1 was a gift from 
Hoffman-La Roche. Complex III was measured using decylub- 
iquinol and cytochrome c as substrates according to Zheng et al. 
[26]. All catalytic activities of OXPHOS complexes were first 
normalized for the citrate synthase activity to account for differ­
ences in recovery of mitochondria (values not shown). These 
ratios then were expressed as the percentage of the mean value 
of the controls.
Western blotting. Mitochondrial proteins, isolated by dif­
ferential centrifugation of homogenized skeletal muscle speci­
mens, were fractionated (2 fag protein/lane) on 10% or 16.5% 
slab gels in a Mini-Protein II apparatus (BioRad) according to 
Schägger and Von Jagow [16]. Proteins were blotted onto
0.2-(im nitrocellulose paper [27].
Rabbit antibodies raised against a synthetic peptide of pre­
dicted internal epitopes of the ND4 and ND6 subunits of human 
complex I, against the purified bovine adenine nucleotide trans- 
locase or against the human ATPase ß subunit were used. The 
latter two were used as an internal standard for mitochondrial 
protein recovery.
Cytochrome-c oxidase (complex IV) was purified from 
human heart mitochondria by preparative blue native electro­
phoresis [14]. Antibodies were raised in rabbits by inoculation 
of the purified complex into lymph nodes according to Sigel et 
al. [28].
The antibodies against the bovine complex I holo-enzyme, 
its 24-kDa subunit and the ND1 subunit of Neurospora crassa 
[29] were kind gifts from Dr U. Harnisch (Department of Bio­
chemistry, University of Düsseldorf), Dr J. Walker (MRC, Cam­
bridge) and Dr S. Werner (Department of Physiological Chemis­
try, University of Munich), respectively.
All antibodies were used at a dilution of 1:1000, except for 
the antibodies against ND4 and ND6, which were used at a 
dilution of 1:100. The ECL kit (Amersham) was used for detec­
tion of bound antibodies.
RESULTS
Muscle morphology. Quadriceps muscle from six patients 
(P2—P7) was histologically examined. From patient PI no histo­
logical report was available. No ragged red fibers were observed 
in patients P2 (isolated complex I defect) and P5 (isolated com­
plex IV defect). The two patients with MELAS showed a higher 
frequency of these fibers (10.7% in P3 and 8.5% in P4), as 
compared to the two patients with CPEO (0.5% in P6 and 0.6%
in P7).
Cytochrome-c oxidase activity was normal in most fibers of 
patient P2, whereas patient P5 had a complete lack of this activ­
ity. The activity in the ragged red fibers of the two patients with 
CPEO (P6 and P7) contrasted with that of the two patients with 
MELAS (P3 and P4). In the CPEO patients the majority of 
ragged red fibers contained no cytochrome-c oxidase, whereas 
this was not the case in the MELAS patients.
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Table 1. Clinical, laboratory and morphological features of patients studied. Ages are given in years unless otherwise specified (d = days,
inf — infantile). For Progression’, t  “  indicates death. Other abbreviations: na, not available; ?, not applicable because of young age; CT/MRI, 
computerized tomography/magnetic resonance imaging.
Feature
Sex
Diagnosis
Age at onset 
Age at biopsy 
Progression 
Hypotonia 
Failure to thrive 
Stroke like episodes 
Seizures 
Retinopathy 
Deafness
Respiratory distress 
Mental retardation 
Ptosis
Short stature
Brain CT/MRI
Lactic acidosis 
Ragged red fibers 
Family history
PI
F
encephalo
myopathy
inf
12d
t27d
+
7f
n
4
+
na
na
+/+
+
P2 
M
failure 
to thrive
inf
1
t4
+
na
/na
P3
M
MELAS
22
25
slow
+
+
H-
•f/na
+
+
P4
F
MELAS
22
22
t23
+
+
+
+
+ /+  
+
+
+
P5
F
encephalo
myopathy
inf
3
t5
+
na
+
na/na
+
P6
M
CPEO
12
22
na
+
—/na
+
P7
M
CPEO
5
11
“h
+
+
/na
Table 2. Quantification of OXPHOS complexes after two-dimensional electrophoresis compared to enzyme activities in fresh 600 g superna- 
tants of patients muscle. Controls were set to 1.00; their values are given as a range ±SD (no.). Stain absolute, total amount of an individual 
complex in 20 mg muscle deduced from protein stain in 2D gels; stain/V, ratio of the absolute stain of an individual complex and complex V from 
the same gel, the quantification being described in Methods; act./CS, ratio of catalytic activities of complexes and citrate synthase. All values are 
normalized to the average values of the controls. Underlined values are below the mean of the control group minus twice its standard deviation 
(P<0.05); nd, not determined.
Sample Complex I Complex III Complex IV Complex V
stain
absolute
Complex
I-III-IV
activity/CSstain/V act./CS stain/V act./CS stain/V act./CS
Controls 0.75—1.42 0.37-1.93 0.81-1.37 0.60-1.39 0.90-1.29 0.42-1.71 0.56-1.74 0.62—1.87
± 0.22 (10) ± 0.42 (26) ±0.16(10) ±  0.24 (24) ±  0.14 (10) ±  0.35 (10) ±  0.43 (10) ±  0.31 (25)
P I (complex I defect) <0.23 0.13 1.23 nd 1.15 0.88 0.66 0.16
P2 (complex I defect) <0.24 0.33 0.96 0.53 0.97 0.72 0.70 0.16
P3 (MELAS) 0.36 0.27 0.58 0.38 0.47 0.58 1.49 0.22
P4 (MELAS) <0.12 0.27 0.52 0.55 0.26 0.24 1.85 0.16
P5 (complex IV defect) 0.94 1.60 0.86 nd 0.20 0.23 0.50 0.36
P6 (CPEO) 0.89 0.84 1.03 nd 1.22 1.18 0.36 1.42
P7 (CPEO) 1.09 0.96 1.33 0.57 0.82 0.72 0.71 0.53
Biochemistry. Substrate oxidation rates in 600 g supernatants of 
fresh muscle homogenates were decreased in all patients, except 
for the two CPEO patients (P6 and P7, results not shown). 
Also the NADH:02 oxidoreductase activity (complex MII-IV, 
Table 2) was severely diminished in the same patients.
An isolated complex I deficiency could be clearly attributed 
to patient PI, as its activity in muscle was only 13% of the 
mean of controls (P<0.05). This observation was confirmed in 
muscle, liver and brain tissue obtained through autopsy after the 
child had died at the age of 27 days.
In patient P2 a decreased complex I activity was measured, 
although this was not statistically significant because of the 
broad range of control values. Since complex III activity was 
also below the normal range, there was some ambiguity about 
possible complex I and/or complex III defects.
In the MELAS patients, low activities of complexes I, III, 
and IV were observed but only the complex III activity of
patient P3 and the complex IV activity of patient P4 were signif­
icantly reduced.
In patient P5 a severe complex IV deficiency was found 
(23 % of mean control value).
The muscle of the two CPEO patients (P6 and P7) did not 
reveal any markedly decreased enzyme activities, which was 
in accordance with the observed normal substrate oxidation 
rates.
Two-dimensional electrophoresis. The electrophoretic and 
quantification techniques were optimized and validated by using 
bovine heart mitochondria and human autopsy specimens. The 
extraction of OXPHOS proteins from mitochondria and tissue 
homogenates and the protein recovery after 2D electrophoresis 
were almost quantitative. The Coomassie staining intensity of 
complexes correlated linearly with the protein load over a much 
broader range than used for analysis of human biopsy specimens 
(experiments not shown).
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the varying absolute amounts of complexes. The standard devia­
tion, e.g. of the complex IV/V ratios in the control group 
(1 ±0.14) was much lower than that of the absolute complex IV 
amounts (1 ±0.34).
In muscle of patients PI and P2 isolated complex I defects 
were identified by the low absolute amounts (not shown) as well 
as by the low complex I/V ratios (Table 2). The results of the 
electrophoretic and enzymic analysis were in parallel but, due 
to the smaller standard deviations of the electrophoretic analysis, 
the complex I/V ratios were clearly below the FC0.05 limit in 
both cases.
The two MELAS patients showed varying degrees of de­
fects. Considering absolute amounts, only a significant reduction 
of complex I in patient P4 was observed (not shown). Complex 
V, in contrast, was normal or moderately increased, as compared 
to the controls, resulting in reduced ratios of all individual com­
plexes relative to complex V. Ratios of complexes and enzymic 
activities paralleled, but only the electrophoretic analysis re­
vealed a significant reduction of all mutual ratios.
In patient P5 the absolute quantities of the complexes were 
generally below the normal range, but only the quantity of com­
plex IV was significantly reduced. The ratios of the complexes 
were normal, except for complex IV (0.20). Thus, a generally 
low content of OXPHOS complexes seemed to be accompanied 
by a severe complex IV defect.
The two CPEO patients (P6 and P7) showed normal ratios 
of the complexes. Only in patient P6 were the absolute staining 
intensities of all complexes below the normal range of controls 
without reaching the level of significance (not shown).
The subunit compositions of all visible complexes were 
found to be normal, and no partially assembled complex could 
be identified in any of the patients.
Western blotting. We tested whether the reduced amounts of 
assembled complexes were caused by a missing subunit, i.e. 
whether individual subunits were present in abnormal ratios. 
Mitochondrial proteins were separated by one-dimensional Tric- 
ine-SDS/PAGE. After the transfer to nitrocellulose paper, the 
blots were incubated with different antibodies.
Reactions of mitochondrial proteins from patients P I —P4 
with antisera against holo-complex I, against single mito- 
chondrially coded subunits (ND1, ND4 and ND6), and a 
nuclear-coded subunit (24kDa), were all diminished, whereas 
the reactions with an antibody against the ATPase ft subunit were 
normal (results not shown). Thus it seemed that the major por­
tion of unassembled subunits was completely degraded.
Antibodies against human heart complex IV that gave a 
strong reaction with all of the larger subunits, including the 
mitochondrially coded subunits I, II and III, were used to screen 
for missing or proteolytically fragmented complex IV subunits. 
An antibody against bovine heart adenine nucleotide translocase 
was used as a reference* Patients P4 and P5, who had strongly 
decreased levels of assembled complex IV in the 2D electropho­
resis, also showed reduced levels of individual cytochrome-c ox­
idase subunits. Reactions with proteolytic fragments were not 
observed, indicating again that unassembled protein subunits 
were proteolytically degraded (results not shown).
DISCUSSION
Morphological, molecular genetic, biochemical, electropho­
retic and Western blotting techniques were applied to character­
ize three groups of OXPHOS defects: CPEO patients with dele­
tions in the mtDNA, MELAS patients with a point mutation in 
the tRNALcu(UUR) gene, and patients with fatal infantile forms
without known mtDNA mutations, who suffered from isolated 
defects either of complex I or of complex IV.
Our special interest was the study of the amounts of assem­
bled OXPHOS enzymes and the mutual ratios of these com­
plexes using a new type of 2D electrophoresis (blue native 
PAGE/Tricine-SDS-PAGE).
The enzymic and 2D electrophoretic approaches, summa­
rized in Table 2, gave similar results; however, the standard 
deviations of controls in the electrophoretic analysis were mark­
edly lower than in the enzymic analysis, allowing the results to 
be interpreted with greater statistical confidence. Both tech­
niques should always be used in parallel because in rare cases, 
which are under investigation, normal amounts of correctly 
assembled complexes were observed at very low catalytic ac­
tivities.
Quantification of a 2D gel from a sample with lower content 
of OXPHOS proteins (around 50 % in patient P5) allowed a sin- 
gle defect of complex IV to be clearly identified by a selectively 
decreased complex IV/V ratio. Since the detection limit of abso­
lute amounts of complex IV in the Coomassie-stained gels was 
reached only at 10% of the mean of the controls (approximately 
20% in the case of complex I defects), missing or hardly detec­
table polypeptide patterns clearly indicate a defect, but enzyme 
activity measurements are required to quantify extremely re­
duced complexes more exactly. More sensitive silver-staining 
procedures were not found to be useful for reliable quantifica­
tion. This may be overcome by the use of suitable antibodies for 
quantitative immunodetection.
The electrophoretic technique using mutual ratios of com­
plexes has the advantage of quantifying all complexes in one 
gel, thus minimizing errors in comparing different samples. 
Since the ratios of complex concentrations were found to be 
fairly constant in the control group and independent of the pro­
tein load, divergent ratios in patients were found to be a superior 
measure to detect OXPHOS defects. Isolated defects of 
OXPHOS complexes, as in patients PI, P2, and P5, could be 
clearly discriminated from multiple defects, as in MELAS 
patients P3 and P4. Furthermore, complex V, which is difficult 
to quantify by enzymic analysis, was easily quantified in 2D 
gels. Complex V defects were not observed in the small number 
of patients studied, but were found in Alzheimer patients (see 
following paper in this volume).
In the case of the two MELAS patients (P3 and P4) a re­
duced rate of mitochondrial protein synthesis [30, 31] would 
account for a low amount of mitochondrial translation products 
and a decreased amount of those complexes that comprise at 
least one mitochondrially coded protein subunit (all, except 
complex II). The enzymic analysis showed that the activities of 
complexes I, III, and IV were differentially affected (Table 2). 
The electrophoretic analysis identified altered mutual ratios of 
complexes even more clearly and demonstrated a hitherto un­
identified effect on complex III, Complex I was more affected 
than complex IV and the ratio of complex III/V was also found 
to be reduced. This order in the extent of the deficiencies seemed 
to parallel the number of subunits encoded in mtDNA of each 
complex: seven, three and one, respectively. However, complex 
V also contains two subunits, ATPase 6 and 8, encoded in 
mtDNA, but was found to be normal or moderately increased 
(Table 2). It is not known whether this apparent discrepancy is 
based on differences at the transcription, translation, or protein 
turnover levels.
Three patients with fatal infantile mitochondrial encephalo- 
myopathy (PI, P2 and P5) had no deletion, depletion, MELAS 
or MERRF mutation, and their muscles lacked ragged red fibers, 
which has also been observed in diseases caused by missense 
mutations in mtDNA, like Leber hereditary optic neuropathy and
beinlaue et al. (tur. J. liiovhem . 2dZ)W
Leigh's syndrome [4], The localization of the defects (specific 
complex I or complex IV deficiencies) was achieved by using 
2D electrophoresis and enzyme activity measurements. No dis­
ease-related missense mutations have been found in the ND 
genes of patient PI (DeVries et al., unpublished results). There­
fore the complex I deficiency in this patient is most probably 
caused by a mutation in one of the nuclear genes of complex I 
or in a gene specifically controlling the assembly of complex I. 
These hypotheses are under present investigation. No partially 
assembled complexes could be identified on the basis of their 
subunit composition (Fig. 1) in any of the 2D gels from patients 
and controls, not even by using more sensitive silver-staining 
techniques.
An OXPHOS defect in CPEO patient P6 seemed to be appar­
ent from the absolute amounts of complexes in 2D electrophore­
sis (32—44% of the mean of controls) that seemed to be in good 
agreement with the observed 50% deleted mtDNA. However, 
this correlation was not found in patient P7 with an even higher 
percentage of deleted mtDNA (75%), but almost normal abso­
lute amounts of complexes. The discrepancy between a high per­
centage of deleted mtDNA and a hardly detectable defect can 
be explained by un uneven distribution of deleted mtDNA in 
the muscle fibers [32, 33]. The few ragged red fibers which 
predominantly lacked cytochrome-c oxidase had increased 
amounts of mtDNA, and have been shown to be almost com­
pletely homoplasmic for the deletion [34], while most other fi­
bers had normal amounts of heteroplasmic mtDNA. This would 
result overall in a high percentage of deletion, but the ratio of 
deleted/wild-type mtDNA would stay below the threshold of 
phenotypic expression in most fibers. In contrast to the CPEO 
patients, the MELAS patients P3 and P4 showed multiple de­
fects at only 50—60% mutated DNA, which is more even dis­
tributed [32, 33].
Western blotting was performed in order to detect potential 
variations in subunit quantities and stoichiometries, i.e. to ana­
lyse both free and correctly assembled subunits. In fact, reduced 
reactions of antibodies correlated with reduced mutual ratios of 
complexes in the electrophoretic and enzymic analysis, but no 
significant deviations from the normal ratio of individual sub­
units in complexes were detected. This observation confirms 
earlier results from other groups, e.g. [13], indicating that free 
subunits, not assembled into complexes, are proteolytically de­
graded, and shows that only the assembled complexes are ana­
lysed by Western blotting, similar to 2D electrophoresis and en­
zymic analysis.
We conclude that 2D electrophoresis (blue native PAGE/ 
Tricine-SDS-PAGE) is a complementary, sensitive and valuable 
new method for the identification of OXPHOS defects in mito­
chondrial encephalomyopathies. Work is in progress to use spe­
cific antibodies and cell cultures to allow identification of par­
tially assembled complexes and free subunits, which could give 
clues to the underlying gene defect in patients.
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